Related Experiment Video
Updated: Jun 25, 2026
06:50
A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
Glycemic control and the injured brain
1Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA. ngentile@temple.edu
Emergency Medicine Clinics of North America
|February 17, 2009
Summary
High blood sugar (hyperglycemia) complicates critical brain injuries, worsening outcomes. Tight glycemic control may improve recovery for patients with acute neurologic illness and injury.
Area of Science:
- Neurology
- Endocrinology
- Critical Care Medicine
Background:
- Hyperglycemia is a complex factor in critical neurologic illness, often both a cause and consequence of brain injury.
- Elevated blood glucose levels in acute neurologic injury correlate with poorer patient outcomes.
- Demographic shifts, including an aging population and changing ethnic diversity, are increasing the prevalence of hyperglycemia and diabetes in neurologic emergencies.
Purpose of the Study:
- To review the epidemiology and pathophysiology of hyperglycemia in acute neurologic injury.
- To examine the application of tight glycemic control in other medical populations.
- To explore the potential of tight glycemic control to enhance outcomes in acute neurologic illness and injury.
Main Methods:
- Literature review of epidemiological data.
- Analysis of pathophysiological mechanisms linking hyperglycemia and brain injury.
- Examination of existing studies on tight glycemic control in diverse patient groups.
Main Results:
- Hyperglycemia is increasingly prevalent in neurologic emergencies due to demographic trends.
- Existing evidence suggests a link between hyperglycemia and adverse neurologic outcomes.
- Tight glycemic control has shown benefits in other critical care settings.
Conclusions:
- Hyperglycemia presents a significant challenge in acute neurologic conditions.
- Further research into tight glycemic control for neurologic injury is warranted.
- Implementing tight glycemic control could potentially improve patient outcomes in critical neurologic illness.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...